COMMERCIALIZATION AGREEMENTCommercialization Agreement • August 4th, 2023 • Tg Therapeutics, Inc. • Pharmaceutical preparations • Delaware
This COMMERCIALIZATION AGREEMENT (this “Agreement”) is entered into as of July 28, 2023 (the “Effective Date”) by and between TG Therapeutics, Inc., a Delaware corporation (“TG Parent”), and TG Biologics, Inc., a Delaware corporation (f/k/a TG Therapeutics, Inc.) (together with TG Parent, “TG”), on the one hand, and Neuraxpharm Pharmaceuticals S.L., a private limited company incorporated under the laws of Spain (“Company”), on the other hand. Each of TG and Company is sometimes referred to individually herein as a “Party” and collectively as the “Parties”.
